These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 31933892)
1. Expression of miR-195 and MEK1 in patients with bladder cancer and their relationship to prognosis. Yang K; Tang H; Ding M; Guo Y; Kai K; Xiao J; Shen Y; Miao S; Zhou R Int J Clin Exp Pathol; 2019; 12(3):843-850. PubMed ID: 31933892 [TBL] [Abstract][Full Text] [Related]
2. Expression of miR-182 and Foxo3a in patients with bladder cancer correlate with prognosis. Chen H; Xu L; Wang L Int J Clin Exp Pathol; 2019; 12(11):4193-4203. PubMed ID: 31933819 [TBL] [Abstract][Full Text] [Related]
3. MiR-203 over-expression promotes prostate cancer cell apoptosis and reduces ADM resistance. Chen LZ; Ding Z; Zhang Y; He ST; Wang XH Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3734-3741. PubMed ID: 29949147 [TBL] [Abstract][Full Text] [Related]
4. MiR-16 inhibits pituitary adenoma cell proliferation via the suppression of ERK/MAPK signal pathway. Wang DW; Wang YQ; Shu HS Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1241-1248. PubMed ID: 29565480 [TBL] [Abstract][Full Text] [Related]
5. MiR-143 regulates proliferation and apoptosis of myelocytic leukemia cell HL-60 via modulating ERK1. Song B; Tang YJ; Zhang WG; Wan CC; Chen Y; Zhang LJ Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3333-3341. PubMed ID: 29917183 [TBL] [Abstract][Full Text] [Related]
6. miR‑101 regulates the cell proliferation and apoptosis in diffuse large B‑cell lymphoma by targeting MEK1 via regulation of the ERK/MAPK signaling pathway. Huang Y; Zou Y; Lin L; Ma X; Zheng R Oncol Rep; 2019 Jan; 41(1):377-386. PubMed ID: 30365139 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of EB virus miR-BART4 inhibits proliferation and aggressiveness while promoting radiosensitivity of nasopharyngeal carcinoma. Wu Q; Han T; Sheng X; Zhang N; Wang P Biomed Pharmacother; 2018 Dec; 108():741-751. PubMed ID: 30248542 [TBL] [Abstract][Full Text] [Related]
8. MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1. Chen XN; Wang KF; Xu ZQ; Li SJ; Liu Q; Fu DH; Wang X; Wu B Cancer Cell Int; 2014; 14():70. PubMed ID: 25414595 [TBL] [Abstract][Full Text] [Related]
9. miR-195 inhibits esophageal cancer cell proliferation and promotes apoptosis by downregulating YAP1. Gao X; Lu M; Xu W; Liu C; Wu J Int J Clin Exp Pathol; 2019; 12(1):275-281. PubMed ID: 31933743 [TBL] [Abstract][Full Text] [Related]
10. Effects of paclitaxel combined with miR-448 on growth and proliferation of bladder cancer EJ cells. Wang Y; Li LJ; Qiu MX; Gong BS Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3363-3369. PubMed ID: 29917187 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-98 promotes drug resistance and regulates mitochondrial dynamics by targeting LASS2 in bladder cancer cells. Luan T; Fu S; Huang L; Zuo Y; Ding M; Li N; Chen J; Wang H; Wang J Exp Cell Res; 2018 Dec; 373(1-2):188-197. PubMed ID: 30463687 [TBL] [Abstract][Full Text] [Related]
12. Role of miR-337-3p and its target Rap1A in modulating proliferation, invasion, migration and apoptosis of cervical cancer cells. Cao XM Cancer Biomark; 2019; 24(3):257-267. PubMed ID: 30883336 [TBL] [Abstract][Full Text] [Related]
13. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells]. Qin AD; Liu XX; Li J; Liu J; Li YS Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764 [No Abstract] [Full Text] [Related]
14. [Expression of Micro-RNA 218 in Cervical Cancer and Its Effect on Proliferation, Apoptosis and Invasion of HeLa Cells]. Shi YR; Liu J; He W; Yang Y Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 47(5):697-702. PubMed ID: 28598082 [TBL] [Abstract][Full Text] [Related]
15. Circ0001429 regulates progression of bladder cancer through binding miR-205-5p and promoting VEGFA expression. Cao W; Zhao Y; Wang L; Huang X Cancer Biomark; 2019; 25(1):101-113. PubMed ID: 30909190 [TBL] [Abstract][Full Text] [Related]
16. Hsa-miR-429 promotes bladder cancer cell proliferation via inhibiting CDKN2B. Yang J; Liu Y; He A; Liu Y; Wu J; Liao X; Lv Z; Wang F; Mei H Oncotarget; 2017 Sep; 8(40):68721-68729. PubMed ID: 28978151 [TBL] [Abstract][Full Text] [Related]
17. MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM. Liu HY; Zhang YY; Zhu BL; Feng FZ; Zhang HT; Yan H; Zhou B J Ovarian Res; 2019 Jul; 12(1):60. PubMed ID: 31277702 [TBL] [Abstract][Full Text] [Related]
18. Up-Regulation of MicroRNA-133a Inhibits the MEK/ERK Signaling Pathway to Promote Cell Apoptosis and Enhance Radio-Sensitivity by Targeting EGFR in Esophageal Cancer In Vivo and In Vitro. Yang QS; Jiang LP; He CY; Tong YN; Liu YY J Cell Biochem; 2017 Sep; 118(9):2625-2634. PubMed ID: 27933650 [TBL] [Abstract][Full Text] [Related]
19. miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway. Sun W; Ping W; Tian Y; Zou W; Liu J; Zu Y Cell Physiol Biochem; 2018; 51(5):2160-2171. PubMed ID: 30522099 [TBL] [Abstract][Full Text] [Related]
20. MiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1. Xia LH; Yan QH; Sun QD; Gao YP Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5546-5553. PubMed ID: 30229827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]